SHANGHAI,Jan. 15,2025-- The hotel market is booming due to tourism growth and rising living standards. Hotel & Shop Plus 2025,organized byIM Sinoexpo,will connect industry professionals with the l
READ MORESHANGHAI,Jan. 16,2025-- A news report from english.shanghai.gov.cn Shanghai announced on Jan 8 plans to encourage the establishment of wholly foreign-owned hospitals in the municipality\'s key economi
NUC Found Guilty of Patent Infringement,Ordered to Cease Activities,Pay Fines SEOUL,South Korea,Jan. 16,2025-- Hurom,the pioneer of low-speed masticating juicers and a global market leader,has succes
SAN FRANCISCO andSUZHOU,China,Jan. 16,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua
SYDNEY,Jan. 16,2025-- The stage is set for one of Australia\'s most prestigious celebrations of small business excellence!
FORNEBU,Norway,Jan. 16,2025-- Reference is made to the announcement byAker Horizons ASA ("Aker Horizons" or the "Company") on 9 January 2025 regarding fixed income investor meeting
NUC Found Guilty of Patent Infringement,Ordered to Cease Activities,Pay Fines SEOUL,South Korea,Jan. 16,2025-- Hurom,the pioneer of low-speed masticating juicers and a global market leader,has succes
SINGAPORE,Jan. 15,2025--ShengShu Technology,a pioneer in generative video,is introducing a game-changing Vidu 2.0 update for its flagship video generation application Vidu. With 10 million users in ju
PISCATAWAY,N.J.,Jan. 14,2025-- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packa
JINJIANG,China,Jan. 14,2025-- With the rising demand for high-quality footwear and private-label customization,finding the right shoe manufacturer has become a critical challenge for businesses in the
DataMan 290 and 390 barcode readers,backed by industry-leading customer support,deliver unmatched reliability and ease of use
SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch
For its third edition,the annual entrepreneurship programme aims to drive change by identifying and supporting women social impact entrepreneurs from South Asia.
© OfficialAffairs
